Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. - Wikidata - awgldk - TriplyDB

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

http://www.wikidata.org/entity/Q33915150

about

Antiepileptic drugs and bone metabolism The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure Adverse effects of antiepileptic drugs on bone mineral density in children.Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Hormonal aspects of epilepsy.Low vitamin D levels are common in patients with epilepsy.Antiepileptic drugs and bone metabolism in children: data from 128 patients.The impact of the use of antiepileptic drugs on the growth of children Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs.Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy rats Antiepileptics and bone health.Epilepsy-related injuries.Calcium and Vitamin D Supplement Prescribing Practices among Providers Caring for Children with Autism Spectrum Disorders: Are We Addressing Bone Health?Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Bone turnover markers in epileptic patients under chronic valproate therapy.Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report.Possible methods for the prevention of bone loss in persons with epilepsy.Bone loss associated with use of antiepileptic drugs.Epilepsy in the elderly: facts and challenges.Influences of bone and mineral metabolism in epilepsy.Epilepsy and menopause.Bone health in adults with epilepsy.Enzyme induction with antiepileptic drugs: cause for concern?Drug-vitamin D interactions: a systematic review of the literature The long-term safety of antiepileptic drugs.Epilepsy and vitamin D.Epilepsy treatment by sacrificing vitamin D.The problem of osteoporosis in epileptic patients taking antiepileptic drugs.Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.Bone mineral density in ambulatory children with epilepsy.Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health.Bone Metabolism Disorder in Epileptic Children.

P2860

Q21245075-F382DDD3-0A85-4374-A969-F351AD83100D Q26739054-A62FCE19-F380-46A2-961A-82E5B89DC44D Q30993847-36039485-5424-4429-BBD7-5AD126E9D2CC Q33283736-D469858D-BEB0-4279-A99A-2BFA1886C222 Q33290977-76B15CF6-D1D0-4226-9C1E-7C7C11AC0DFA Q33638313-8B26005C-F310-4545-857B-6037F79A5948 Q34112172-C498E0FC-CF2C-4257-9D4C-09488BC695E8 Q34253275-FAB82449-3862-46F1-9FBD-13712A27B038 Q35071970-E46A21E7-C979-4BA6-A285-B4804A1A8519 Q35115128-3C9A423B-2CF1-4B78-ACA8-775E79E81061 Q35165033-A6AF6F14-70CD-411A-8464-8F0F761BACCD Q35184525-B32AB0F6-A97A-4C69-8ED5-2C6F0156E4FB Q36059549-CE55A812-000F-412F-985F-50DD3A3BE723 Q36625022-0E22B9F6-16D3-4F22-A057-3A4D52EAEB04 Q36706428-C079BBED-9508-47D4-B90A-D40082880014 Q37178973-1B6E8531-B12A-45E1-B156-DAAC1B0F7EF5 Q37213531-D61B34D4-49A8-42E9-9A2C-75A0E53D9488 Q37222165-0ECFBF0E-D2B6-48BC-88C1-598EC2D30DF8 Q37338208-B5F3C019-7335-4CC5-A557-EC1F8512CEBB Q37507951-145A7ED1-65C5-4F58-90B9-36132AFFB16B Q37702229-22EE6AB3-631D-4596-9BD7-25699AE8DE43 Q37818528-B7FEC518-43D1-4E32-8994-BC15F8A0B6FE Q37842459-6F45DC36-2342-47A2-ABDF-65676A6F3E43 Q37887545-EA06CFDB-DA0F-43C4-B1A3-C951DEC12715 Q37895322-89961EAC-1037-41FF-AAC3-D379C0CBF392 Q38046892-FB376310-DAA5-450C-90FA-3716F854B088 Q38073239-796EFE7E-04A9-4FCE-B7A9-AAAE0AD5CB06 Q38106856-B55B694E-AC8A-4011-A8F0-E08E4E06E9A7 Q38142332-1266CBED-7685-43F6-AB9C-538E8D8CF555 Q38205010-4556F019-CE57-4482-93BC-8B88ED7AE32F Q38211406-1DAC9FB4-5C18-4638-99E8-6090E28C8A47 Q38640619-E04A2FA7-5D79-4727-A1AE-2D9F05A6464A Q46293491-4A2910F1-BF67-4A1D-82D5-20881E9FD833 Q46313804-C0D0B412-0247-4BE8-A118-53D8E3136092 Q46489842-1B3A653D-7E4E-4071-9F32-709F69CF08DB Q46984906-D00C5640-6EDD-4A46-93FD-57F7ABFDD411 Q51059654-ED377E8F-E182-424E-9C78-E06B82190B2B Q52985197-C725FE40-2202-4F2A-9318-930C3B5EDB62 Q53691422-65B9D9BC-0182-4E5C-A625-9E07BEDFD6DE

P2860

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

http://www.wikidata.org/entity/Q33915150

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@ast

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@en

type

label

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@ast

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@en

prefLabel

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@ast

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@en

P1433

Q33915150-FD517E94-C900-4EF3-A741-832213DE21B0

P1476

Q33915150-2BB37153-00DD-4BA6-8F25-54F03B76AE3F

P2093

Q33915150-0E55B243-10AD-4D4F-A62F-E7B74C8114D0

Q33915150-2F89696B-CDEF-4C65-92C8-493F46F4CFCB

Q33915150-3B7A0601-9682-408B-82DB-04E956B3CA4B

Q33915150-41C9EDE5-3393-47B5-931A-4BFC26648B7E

Q33915150-9DE9623A-ADCF-4E0B-9472-049CE9A8ECE9

Q33915150-B01A5721-5749-4EB3-9B27-C6D4593E9A9F

Q33915150-B7C7699D-54B3-41F7-A226-5D80F4030FE2

Q33915150-CA50D890-3DBF-41B4-995D-756335A57133

Q33915150-FEA05C06-CD17-447C-A0BD-C6B7C5EBFE83

P2860

Q33915150-063E9866-8242-44FC-9342-24A6B2D04675

Q33915150-1715F4EE-94F0-44D4-8FB1-DAB2AC325780

Q33915150-2E434782-9DE8-4FA9-B774-2A8D907E8343

Q33915150-3B657DC9-EEDE-4B0F-9F43-370F8BE37845

Q33915150-5D4035EB-A340-4F40-9D26-7CFCB5C3D23F

Q33915150-774517D5-0C81-4715-A5A9-76B517C29054

Q33915150-88FDB794-3CA4-47D8-8338-5D4B62C99571

Q33915150-8AFF606C-A36E-4900-97B2-8A5674368845

Q33915150-8D258F20-99AE-4ECF-9537-C5EF6FA3765E

Q33915150-9702C1DD-C24E-4ABA-9C2D-57AB7A2672B2

P304

Q33915150-B962B6A9-5183-4F5F-83B3-59D8AECABC1D

P31

Q33915150-0B755311-1B17-4770-93BA-D4B7964C1D3A

P356

Q33915150-AEEE76F9-B300-427B-BA43-CD64E662C4A0

P433

Q33915150-7DC7E726-F314-4CCC-80D1-F9A09F8F3CDE

P478

Q33915150-790529EB-8979-46AD-8DDA-49D7D639D391

P577

Q33915150-B5B66883-7EAD-4265-AF86-0033BD33BF7F

P698

Q33915150-E0E7D394-FFE3-4952-A89B-72EE54AC471A

P932

Q33915150-55C8C27E-BE3F-4C4C-8F53-82B328BD3C0B

P356

P1433

Annals of Neurology

P1476

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

@en

P2093

Alison M Pack

http://www.w3.org/2001/XMLSchema#string

Alison Randall

http://www.w3.org/2001/XMLSchema#string

Cairn Seale

http://www.w3.org/2001/XMLSchema#string

Edith Flaster

http://www.w3.org/2001/XMLSchema#string

Elizabeth Shane

http://www.w3.org/2001/XMLSchema#string

Leah Holloway

http://www.w3.org/2001/XMLSchema#string

Martha J Morrell

http://www.w3.org/2001/XMLSchema#string

Robert Marcus

http://www.w3.org/2001/XMLSchema#string

Silvia Doñe

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls.

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

A data-based approach to diet questionnaire design and testing.

Biochemical markers of bone turnover and fracture prediction.

Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro

The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy.

Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats.

Antiepileptic drug-induced bone loss in young male patients who have seizures.

P304

252-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.20378

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15668966

http://www.w3.org/2001/XMLSchema#string

P932

4102137

http://www.w3.org/2001/XMLSchema#string